Noul
Yongsin
About Noul
Noul offers solutions for chronic and systemic problems in healthcare. Noul adapts invitro diagnostics to improve medical access with innovative diagnostic solutions. It focuses on enhancing human health by contributing to the eradication of infectious and non-infectious diseases that are considered as some of the threats to global health.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $3.1M
- Last round: Grant (Mar 2023)
- Website: noul.com
- Phone: +82-31-308-6310
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Health Diagnostics, Product Research
Social Profiles
Canonical: https://fsome.com/organization/noul-17187 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.